NCT02306460 Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation Status TERMINATED Phase N/A
NCT02298244 Safety Procedure Pulmonary Artery Denervation in Addition to Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation in Patients With Persistent Atrial Fibrillation and Pulmonary Hypertension Status UNKNOWN Phase NA
NCT02294955 Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial) Status UNKNOWN Phase NA
NCT02294929 Cryoballoon Ablation in Patients With Longstanding Persistent Atrial Fibrillation Status UNKNOWN Phase NA
NCT02286414 Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over Status COMPLETED Phase N/A
NCT02283294 Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation Status COMPLETED Phase PHASE3
NCT02273700 Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention Status COMPLETED Phase N/A
NCT02270151 Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick Status COMPLETED Phase PHASE3
NCT02270112 Enhanced Diagnostics for Early Detection of Atrial Fibrillation Status COMPLETED Phase N/A
NCT02269774 Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea Status TERMINATED Phase NA
NCT02268799 High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter Status COMPLETED Phase N/A
NCT02267889 Ganglionated Plexus Ablation For Treatment of Atrial Fibrillation Status COMPLETED Phase NA
NCT02262676 Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain Status COMPLETED Phase N/A